CW July 2002Issue Number 7 July 2002 ISSN 10593802 News In BriefThis months News in Brief deals with:
MS-209, a new quinoline-type reversal agent in multidrug resistance (MDR); Heparanase expression in postoperative survival after pancreatectomy for cancer; Protein kinase D, a new regulator; Hereditary prostate cancer; Oral cancer; Genetic testing for breast cancer risk: the Canadian experience. Go to Next Page Source & Additional Reading Clin. Cancer Res. 8, 582-588, 2002. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW July 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |